VS
Compare Harvest Healthcare Leaders Income ETF (HHL) vs Brompton Global Healthcare Income & Growth ETF (HIG) to find the best fit for your portfolio. HHL provides Healthcare and Sovereign exposures, while HIG is primarily weighted in Healthcare, Finance, and Consumer Non-Cyclicals. When evaluating costs, HHL features a management fee (MER) of 0.85%, compared to 0.75% for HIG. Performance-wise, HHL has returned 0.32% year-to-date with +$354 M in net flows, whereas HIG is at 0.67% with +$10 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
HHL
HIG
| AuM | $1,833.20 M | $66.60 M |
| Management Fees | 0.85% | 0.75% |
| Exp. ratio | 0.98% | 0.96% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 8, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | HHL | -3.52% | +4.74% | -0.32% | +8.86% | +18.71% |
HIG | -1.43% | +6.63% | -0.67% | +8.32% | +14.56% | |
| Flows | HHL | -$1 M | +$41 M | +$354 M | +$356 M | +$688 M |
HIG | -$0 M | +$2 M | +$10 M | +$12 M | +$22 M |
HHL vs HIG exposure
Countries
HHL
USA
84.21%
Other
15.79%
HIG
USA
81.56%
Other
18.44%
Sectors
HHL
Healthcare
98.89%
HIG
Healthcare
90.44%
Other
9.56%
As of September 8, 2026
Top 10 Holdings
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
HIG
Johnson & Johnson
5.95%
Novartis AG
5.63%
Cardinal Health, Inc.
5.30%
Eli Lilly & Co.
5.26%
Bristol Myers Squibb Co.
5.20%
UnitedHealth Group, Inc.
4.90%
Gilead Sciences, Inc.
4.86%
Agilent Technologies, Inc.
4.59%
Welltower, Inc.
4.45%
Vertex Pharmaceuticals, Inc.
4.44%
Diversification
HHL
Total weight of top 10 holdings out of 25 total
50.34%
HIG
Total weight of top 10 holdings out of 25 total
50.57%
Characteristics
Compare
HHL
HIG
| Provider | Harvest Portfolios Group | Brompton Group |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 10.03% | 8.89% |
| Meets ESG criteria | No | No |
| Inception Date | December 18, 2014 | September 24, 2015 |
Frequently asked questions about HHL and HIG
Which ETF has performed better year to date: HHL or HIG?
As of September 8, 2026, HHL has returned -0.32% year to date, while HIG has returned -0.67%. HHL is ahead on YTD performance.
Which ETF is larger by assets under management: HHL or HIG?
As of September 8, 2026, HHL manages $1.83 B in assets, while HIG manages $66.60 M. HHL is the larger fund by AUM.
How are HHL and HIG managed?
HHL is actively managed by Harvest Portfolios Group. It does not track an index. HIG is actively managed by Brompton Group. It does not track an index.
What sectors do HHL and HIG emphasize?
HHL is most exposed to Healthcare and Sovereign. HIG is most exposed to Healthcare, Finance, and Consumer Non-Cyclicals.
Which ETF is attracting more investor flows: HHL or HIG?
Year to date, HHL has seen +$354.17 M in net flows, compared with +$9.82 M for HIG. HHL has attracted more net investor money so far.
How do the fees of HHL and HIG compare?
HHL has an expense ratio of 0.98%, while HIG has an expense ratio of 0.96%.
What are the top holdings of HHL and HIG?
HHL's largest holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co.. HIG's top holdings include Johnson & Johnson, Novartis AG, and Cardinal Health, Inc..
Which ETF is more diversified: HHL or HIG?
HHL holds 25 securities, while HIG holds 25. On holdings count, HHL is the more diversified portfolio.
Recent articles about HHL and HIG
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.